Evolva Holding SA, a biosynthetic company, discovers and develops ingredients and processes for food, nutrition, and pharmaceutical products. The company uses its yeast-based platform for the production of ingredients. Its nutrition projects are aimed at developing alternative and sustainable routes to produce ingredients through fermentation. The company’s principal products include vanillin, a flavoring ingredient with IFF; steviol glycosides, a natural zero-calorie sweetener stevia with Cargill; saffron, a spice for coloring and flavoring; and resveratrol, a natural product occurring in grapes with potential health benefits. It also offers Pomecins compounds that prevent mould and yeast growth; EV-077 for the treatment of diabetic complications; and EV-035, a novel bacterial type II topoisomerase inhibitor that address the threat of bad bugs. The company operates in Switzerland, Denmark, India, and the United States. Evolva Holding SA is headquartered in Reinach, Switzerland.
evolva holding sa (EVE:SIX Swiss Ex)
Phone: 41 61 485 20 00
Fax: 41 61 485 20 01www.evolva.com
|No competitor information is available for EVE.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA | Mack-sumner CommunicationsPosted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26
Sponsored Financial Commentaries
To contact EVOLVA HOLDING SA, please visit www.evolva.com. Company data is provided by Capital IQ. Please use this form to report any data issues.